SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Space Exploration Technologies Corp., doing business as SpaceX, operates as an aerospace manufacturer, launch service provider, and satellite communications company. It is building the integrated hardware and software infrastructure of the future across space, connectivity, and AI. The firm designs, manufactures, launches, and operates products and services built on cutting-edge technologies, including the rockets and spacecraft.The company was founded by Elon Reeve Musk in 2002 and is headquartered in Starbase, TX.

Space Exploration Technologies Corp. - Ordinary Shares - Class A

SpaceX

SPCX is experiencing extreme volatility following its massive IPO as investors debate the impact of the newly announced $60 billion all-stock acquisition of AI startup Cursor. Community discussion remains polarized, with bulls betting on aggressive growth and Elon Musk's long-term vision, while skeptics are pointing to significant dilution concerns, the lack of current profitability, and a tight initial float that has created a hot-potato environment.

SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.

SELLAS Life Sciences Group Inc

SELLAS Life Sciences is under heavy community scrutiny as investors brace for the final data readout from its Phase 3 REGAL trial, with intense debate centered on the upcoming vote for a 20 million share RSU expansion. While bulls argue that the extended trial duration and recent protocol adjustments indicate strong patient survival and a potentially curative treatment for AML, bears and skeptics are voicing significant concerns regarding potential shareholder dilution and the historical failure of similar cancer vaccine programs.

Rackspace Technology, Inc. engages in the provision of end-to-end multi-cloud technology services. The firm designs, builds and operates its customers’ cloud environments across technology platforms. It operates through the following segments: Multicloud Services and Apps & Cross Platform. The Multicloud Services segment includes public and private cloud managed services offerings, as well as professional services related to designing and building multicloud solutions and cloud-native applications. The Apps & Cross Platform segment includes managed applications, managed security and data services, as well as professional services related to designing and implementing application, security and data services. The company was founded on July 21, 2016 and is headquartered in San Antonio, TX.

Rackspace Technology Inc

Rackspace Technology is trending as shares surge following a 15% workforce reduction to reinvest in AI and a major deal with AMD for the phased deployment of an AI compute footprint. Investors are actively discussing the growth potential of this AI-focused pivot, with community sentiment split between excitement over the contract's scale and debates regarding the company's debt and potential for future share offerings.

Dave & Buster's Entertainment, Inc. engages in the ownership and operation of entertainment and dining venues under the name Dave & Buster's. It offers a full menu of entrées and appetizers, a selection of alcoholic and non-alcoholic beverages, and an assortment of entertainment attractions centered around playing games and watching live sports and other televised events. The company was founded by David O. Corriveau and James W. Corley in 1982 and is headquartered in Coppell, TX.

Dave & Buster`s Entertainment Inc

Dave & Buster's Entertainment

Dave & Buster's is facing significant downward pressure following a disappointing quarterly earnings report that missed both revenue and EPS estimates, fueling community speculation about the company's financial stability. While some investors view the current beaten-down price as a potential deep-value buying opportunity, the broader community remains divided, with active discussions focusing on concerns over debt levels, management strategy, and whether a turnaround is realistic.

Western Digital Corp. engages in the development, manufacture, marketing, and sale of data storage devices and solutions. The company was founded by Alvin B. Phillips in 1970 and is headquartered in San Jose, CA.

Western Digital Corp.

Western Digital is experiencing significant momentum driven by robust institutional demand for high-capacity storage, particularly as hyperscale data centers scramble to secure supply for artificial intelligence workloads. The community remains highly focused on the storage sector's massive cyclical turnaround, with active discussions debating whether the stock's recent ascent represents a sustainable re-rating tied to pricing power or a speculative bubble reminiscent of past tech cycles.

Eos Energy Enterprises, Inc. designs, manufactures, and deploys battery storage solutions for the electricity industry. It offers the Eos Znyth DC battery system product which designs to meet the requirements of the grid-scale energy storage market. The company was founded in 2008 and is headquartered in Edison, NJ.

Eos Energy Enterprises Inc - Ordinary Shares - Class A

Eos Energy Enterprises is trending as investors react to a major strategic framework agreement involving Frontier Power USA and Stella Energy Solutions, which aims to convert a significant project pipeline into long-term demand for its zinc-based storage technology. Despite volatility and intense short interest, the community is actively debating the stock's potential as a critical AI infrastructure play, focusing on the company's recent earnings beat, production scaling at its Thorn Hill facility, and the broader grid-scale energy storage demand.

Moderna, Inc. engages in the development of transformative medicines based on messenger ribonucleic acid. The firm's product pipeline includes the following modalities: prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, inhaled pulmonary therapeutics and systemic intracellular therapeutics. It operates through the following geographical segments: United States, Europe, and Rest of World. The company was founded by Noubar B. Afeyan, Robert S. Langer, Jr., Derrick J. Rossi, and Kenneth R. Chien in 2010 and is headquartered in Cambridge, MA.

Moderna Inc

Moderna is trending as investors weigh potential new vaccine development opportunities amid recent global health headlines regarding emerging viral outbreaks. The community is actively debating the company's long-term oncology pipeline and the impact of broader biotech sector volatility on its market performance.

One Stop Systems, Inc. engages in the design, manufacture, and marketing of computing modules and systems targeting edge deployments. It deals with the design and manufacture of high-performance customized computer and flash arrays, in-flight entertainment, and connectivity and value-added reseller with minimal customization. The company operates through the OSS and OSS Europe segments. One Stop Systems was founded by Stephen D. Cooper and Mark Gunn in 1998 and is headquartered in Escondido, CA.

One Stop Systems Inc

One Stop Systems is surging following an earnings report that highlighted record bookings, double-digit revenue growth, and a strong pipeline in Edge AI and defense sectors. The community is actively discussing the company's expansion into mission-critical military applications, with many investors anticipating long-term valuation growth driven by a solid cash position and upcoming potential defense contracts.

Syntec Optics Holdings, Inc. engages in the design and manufacture of optics and photonics enabled products. The company was founded in 1981 and is headquartered in Rochester, NY.

Syntec Optics Holdings Inc. - Ordinary Shares - Class A

Syntec Optics Holdings Inc

Syntec Optics (OPTX) is seeing intense investor focus as the company scales production for critical defense and aerospace initiatives, including optics for LEO satellite constellations and advanced military helmet systems. The community is heavily debating its long-term potential as an AI infrastructure enabler, while closely monitoring the stock's tight float and the potential for a short-squeeze as institutional activity grows.

Mobileye Global, Inc. engages in the business of developing and deploying driver assistance systems and autonomous driving technologies and solutions. It operates under the Mobileye and Other segments. The company was founded by Amnon Shashua and Ziv Aviram in 1999 and is headquartered in Jerusalem, Israel.

Mobileye Global Inc - Ordinary Shares - Class A

MOBILEYE GLOBAL INC

Mobileye is trending as the company transitions into a vertically integrated robotaxi business, with the community actively debating the potential for an asymmetric upside play versus concerns over intense competition and historical price volatility. Investors are closely monitoring the shift from a traditional autonomous driving supplier to a commercial fleet operator, with sentiment split between those viewing the current valuation as an unmissable entry point for physical AI exposure and others skeptical of the company's ability to compete against established robotaxi incumbents.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Haemonetics Updates Financial Reporting Segments

Haemonetics Updates Financial Reporting Segments Haemonetics Updates Financial Reporting Segments PR Newswire BOSTON, June 5, 2026 BOSTON, June 5, 2026 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative solutions designed to...

Haemonetics to Present at Goldman Sachs 47th Annual Global Healthcare Conference

Haemonetics to Present at Goldman Sachs 47th Annual Global Healthcare Conference Haemonetics to Present at Goldman Sachs 47th Annual Global Healthcare Conference PR Newswire BOSTON, June 2, 2026 BOSTON, June 2, 2026 /PRNewswire/ --Haemonetics Corporation (NYSE: HAE) announced that Chris Simon...

Haemonetics (HAE) Shares Cross Above 200 DMA

In trading on Friday, shares of Haemonetics Corp. (Symbol: HAE) crossed above their 200 day moving average of $62.24, changing hands as high as $65.84 per share. Haemonetics Corp. shares are currently trading up about 5.1% on the day. The chart below shows the one year perform...

Investing in Haemonetics (HAE)? Don't Miss Assessing Its International Revenue Trends

Examine the evolution of Haemonetics' (HAE) overseas revenue trends and their effects on Wall Street's forecasts and the stock's prospects.

Is the Options Market Predicting a Spike in Haemonetics Stock?

Investors need to pay close attention to GBTG stock based on the movements in the options market lately.

HAE Stock Gains on Q4 Earnings & Revenue Beat, Gross Margin Cut

Haemonetics beats Q4 EPS and revenue estimates, shares rise 1.4%, but gross margin falls 120 basis points as the company sets its FY27 growth outlook.

Haemonetics Q4 Earnings Call Highlights

Haemonetics Q4 Earnings Call Highlights...

Haemonetics (HAE) Q4 2026 Earnings Transcript

@media (max-width: 768px) {
 .image-container {
 width: 100% !important;
 float: none !important;
 margin: 0 0 1rem 0 !important;
 }
 }

Image source: The Mo...

Haemonetics (HAE) Reports Q4 Earnings: What Key Metrics Have to Say

Although the revenue and EPS for Haemonetics (HAE) give a sense of how its business performed in the quarter ended March 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

Haemonetics (HAE) Q4 Earnings and Revenues Surpass Estimates

Haemonetics (HAE) delivered earnings and revenue surprises of +1.04% and +2.43%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Haemonetics Corp. engages in the development and distribution of hematology products and solutions. It operates through the following segments: Plasma, Blood Center, and Hospital. The Plasma segment offers automated plasma collection and donor management software systems. The Blood Center segment provides solutions for donor collection centers' ability to acquire blood, filter blood, and separate blood components. The Hospital segment includes hemostasis management, cell salvage, and transfusion management services that help decision makers in hospitals optimize blood acquisition, storage, and usage in critical settings. The company was founded by Allen Latham, Jr. in 1971 and is headquartered in Boston, MA.

Current Price	$76.91
Prev Close	$78.20
Open	$77.95
Dividend Yield	0.00%
50-Day Moving Average	$62.50
Beta	0.64
Avg. Volume	1.01M
PE Ratio	37.85

52-Week High	$87.32
52-Week Low	$47.32
Market Capitalization	$3.5B
EPS (Annual)	$2.05
Price to Book	4.37
Revenue Per Employee	$443,345.63

HAEHaemonetics Corp.

Fundamentals

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest HAE News